Biotech new drug development company market valueevaluation : OBI Pharma Case Study
碩士 === 國立臺灣大學 === 國際企業管理組 === 106 === Biotechnology has been selected as one of the key industries in Taiwan and is a high capitalization, high research oriented and high risk but high return industry. Internationally, merge and acquisition have been the global trend for the big pharma in order to e...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/kdh9h6 |